Sanofi agreed to buy Dynavax Technologies Corp. for about $2.2 billion, as it seeks to expand a vaccines business currently ...

No one wants to see the smallest family members down for the count, but Tampa Bay area doctors said more kids are coming in ...

A strict new vaccine approval process in the U.S. could dramatically slow things down for biopharma and the public, experts ...

The Vaccine Adverse Event Reporting System (VAERS) was established to protect public health. Now it's being used against it.

Six days after a senior FDA official sent a sweeping internal email claiming that COVID vaccines had caused the deaths of "at ...

Policy initiatives have come fast and furious at the FDA this year. While guidances on rare diseases and vaccines have consumed most of the ink, policy shifts aimed at improving FDA efficiencies and ...

Now you can give yourself a flu vaccine at home. Should you try it? If you have a fear of needles and are nervous about getting the flu shot, you’re not alone. It’s estimated that up to 25% of adults ...

Echoing a longstanding anti-vaccine trope, President Donald Trump falsely claimed that the American vaccine schedule "long ...

FDA Commissioner Martin Makary discusses vaccine policy, COVID-era decisions and the erosion of trust in government health ...

In a phase I trial, an intranasal adjuvanted recombinant influenza vaccine appeared to result in response to a range of H5N1 clades. The adjuvanted vaccine elicited seroconversion against clade 2 ...